<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?</h2>
    <div class="badge">2025-09-15T13:40:02+00:00</div>
    <ul>
      <li>The stock is up 56.2% year-to-date.</li>
<li>The industry has moved +3.6% so far this year.</li>
<li>Based on the most recent data, BSX has returned 15% so far this year.</li>
<li>Meanwhile, the Medical sector has returned an average of -1.8% on a year-to-date basis.</li>
<li>Over the past three months, Akero Therapeutics, Inc.&#x27;s consensus EPS estimate for the current year has increased 2.7%.</li>
<li>Over the past 90 days, the Zacks Consensus Estimate for BSX&#x27;s full-year earnings has moved 2.1% higher.</li>
<li>On average, stocks in this group have gained 6.7% this year, meaning that BSX is performing better in terms of year-to-date returns.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Is%20Boston%20Scientific%20%28BSX%29%20Outperforming%20Other%20Medical%20Stocks%20This%20Year%3F%0A%E2%80%A2%20The%20stock%20is%20up%2056.2%25%20year-to-date.%0A%E2%80%A2%20The%20industry%20has%20moved%20%2B3.6%25%20so%20far%20this%20year.%0A%E2%80%A2%20Based%20on%20the%20most%20recent%20data%2C%20BSX%20has%20returned%2015%25%20so%20far%20this%20year.%0A%E2%80%A2%20Meanwhile%2C%20the%20Medical%20sector%20has%20returned%20an%20average%20of%20-1.8%25%20on%20a%20year-to-date%20basis.%0A%E2%80%A2%20Over%20the%20past%20three%20months%2C%20Akero%20Therapeutics%2C%20Inc.%27s%20consensus%20EPS%20estimate%20for%20the%20current%20year%20has%20increased%202.7%25.%0A%E2%80%A2%20Over%20the%20past%2090%20days%2C%20the%20Zacks%20Consensus%20Estimate%20for%20BSX%27s%20full-year%20earnings%20has%20moved%202.1%25%20higher.%0A%E2%80%A2%20On%20average%2C%20stocks%20in%20this%20group%20have%20gained%206.7%25%20this%20year%2C%20meaning%20that%20BSX%20is%20performing%20better%20in%20terms%20of%20year-to-date%20returns.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fis-boston-scientific-bsx-outperforming-other-medical-stocks-this-year%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/boston-scientific-bsx-outperforming-other-134002772.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>